Login / Signup

Identification of ATM Mutation as a Potential Prognostic Biomarker for Immune Checkpoint Inhibitors Therapy.

Saijin CuiTianyu ChenYaning ZhaoZhuoyun XiaoMeitong LiuXi HuangShiru CaoRongmiao ZhouYou LiXiangran HuoNa Wang
Published in: Current cancer drug targets (2024)
Our findings highlight the value of ATM mutation as a promising biomarker to predict ICIs therapy in multiple tumors.
Keyphrases
  • dna damage
  • dna repair
  • dna damage response
  • risk assessment
  • mesenchymal stem cells